Literature DB >> 29317219

Icariin inhibits LPS-induced cell inflammatory response by promoting GRα nuclear translocation and upregulating GRα expression.

Xianjun Sun1, Xiaohong Deng1, Waijiao Cai1, Wenwei Li2, Ziyin Shen1, Tinghui Jiang3, Jianhua Huang4.   

Abstract

AIMS: Icariin (ICA) is a flavonoid isolated from certain plant species in the genus Epimedium, especially Epimedium brevicornum. Previous studies indicated that ICA has certain regulatory effects on some inflammatory diseases, and that ICA regulates the activity of glucocorticoid receptor (GR) and NF-κB. But the causal link between GR and NF-κB and other downstream pathways in effects of ICA remained elusive, therefore here we have investigated whether ICA could promote GR function, in turn, to regulate NF-κB and/or other factors to achieve its anti-inflammatory effect. MAIN
METHODS: Inflammatory cell models were induced by lipopolysaccharide (LPS) in RAW 264.7 and HeLa cell line. Observation of GRα nuclear translocation by confocal laser scanning microscopy. GRα and inflammatory cytokines expression was detected by RT-qPCR, Western Blotting and ELISA. Co-immunoprecipitation technique was used to detect the binding of GRα to downstream transcription factors. GRα activity was blocked by GRα antagonist RU486, and GR downstream transcription factors including NF-κB, c-Jun, and Stat3 were silenced by corresponding RNA interference. KEY
FINDINGS: In both inflammatory cell models, ICA decreased LPS-induced production of inflammatory cytokines (IL-6 and TNF-α). While ICA up-regulated the amount of GRα and promoted its nucleus translocation. The increased GRα in the nucleus by ICA bound more NF-κB, c-Jun, and Stat3. Blockade GRα and silence of NF-κB, c-Jun, and Stat3 expression partially abolished the anti-inflammatory effects of ICA. SIGNIFICANCE: Promoted GR function and the consequent inhibition of pro-inflammatory transcription factors contribute a main mechanism by which ICA exerts its anti-inflammatory effect.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  C-Jun; Icariin; Inflammation; NF-κB; Stat3; glucocorticoid receptor-α

Mesh:

Substances:

Year:  2018        PMID: 29317219     DOI: 10.1016/j.lfs.2018.01.006

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  [Icariin alleviates lipid peroxidation after spinal cord injury in rats].

Authors:  Xian-Sheng Ren; Wei Ding; Xiao-Yu Yang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-06-20

2.  Epimedium sagittatum inhibits TLR4/MD-2 mediated NF-κB signaling pathway with anti-inflammatory activity.

Authors:  Ni Yan; Ding-Sheng Wen; Yue-Rui Zhao; Shun-Jun Xu
Journal:  BMC Complement Altern Med       Date:  2018-11-13       Impact factor: 3.659

3.  Icariin Activates Autophagy via Down-Regulation of the NF-κB Signaling-Mediated Apoptosis in Chondrocytes.

Authors:  Bobin Mi; Junqing Wang; Yi Liu; Jing Liu; Liangcong Hu; Adriana C Panayi; Guohui Liu; Wu Zhou
Journal:  Front Pharmacol       Date:  2018-06-06       Impact factor: 5.810

4.  Inhibition of airway remodeling and inflammatory response by Icariin in asthma.

Authors:  Lingli Hu; Lulu Li; Hongying Zhang; Qiuping Li; Shan Jiang; Jian Qiu; Jing Sun; Jingcheng Dong
Journal:  BMC Complement Altern Med       Date:  2019-11-19       Impact factor: 3.659

Review 5.  Phytochemicals Mediate Autophagy Against Osteoarthritis by Maintaining Cartilage Homeostasis.

Authors:  Zheng Tian; Xinan Zhang; Mingli Sun
Journal:  Front Pharmacol       Date:  2021-12-20       Impact factor: 5.810

6.  Efficacy and safety of modified Bushen Yiqi formulas (MBYF) as an add-on to formoterol and budesonide in the management of COPD: study protocol for a multicentre, double-blind, placebo-controlled, parallel-group, randomized clinical trial: FB-MBYF Trial.

Authors:  Qing Kong; Yuxue Cao; Zhen Gao; Jing Sun; Hongying Zhang; Yijie Du; Yubao Lv; Sihan Zhou; Zihui Tang; Baojun Liu; Jingcheng Dong
Journal:  Trials       Date:  2022-02-14       Impact factor: 2.279

7.  A novel hierarchical biofunctionalized 3D-printed porous Ti6Al4V scaffold with enhanced osteoporotic osseointegration through osteoimmunomodulation.

Authors:  Wei Wang; Yinze Xiong; Renliang Zhao; Xiang Li; Weitao Jia
Journal:  J Nanobiotechnology       Date:  2022-02-05       Impact factor: 10.435

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.